Author | Kendra Sweet, MD | OncLive

Author | Kendra Sweet, MD

Articles

Dr. Sweet Discusses TKI Discontinuation in CML

August 31, 2018

Video

Kendra Sweet, MD, an assistant member in the Department of Malignant Hematology at Moffitt Cancer Center, discusses discontinuation of tyrosine kinase inhibitor (TKI) therapy in chronic myeloid leukemia.

x